ANI Pharmaceuticals Inc - ANIP Operatsion rentabellik

ANIP (ANI Pharmaceuticals Corp) - kompaniyaning tovar belgisi

ANI Pharmaceuticals muhim dori vositalariga bo'lgan talab tufayli iqtisodiy pasayishlarga nisbatan barqarorligini saqlamoqda. Kompaniya kengayish uchun noyob patologiyalar va murakkab generiklarga tayanmoqda. Operatsion foyda marjalari GURU.Markets tizimidagi ushbu grafikda aks ettirilgan bo'lib, unda 15.30 oxirgi metrika darajasini ifodalaydi. O'sish liniyalarni avtomatlashtirishga va R&D doirasida yangi formulalarni izlashga asoslangan.

ANIP: anipharmaceuticals.com Operatsion foyda normasi 04.07.2022 - 19.11.2026

anipharmaceuticals.com - tahliliy kesimlar va asosiy koʻrsatkichlar (ANIP)

Kompaniyaning har tomonlama tahlili:ANI Pharmaceuticals Inc, ANIP
ANI Pharmaceuticals asosiy tovari

ANI Pharmaceuticals ommaviy bozor generiklarini ishlab chiqarishni yuqori narxli orfan dori vositalari savdosi bilan samarali birlashtirib, eksklyuziv nishalar orqali narxlar raqobatini neytrallashtiradi. Ushbu ko'rsatkich operatsion foydaning tushumga nisbatini aks ettirib, xarajatlarni boshqarish samaradorligi va real biznesning daromadliligini namoyish etadi, bu esa investorga asosiy operatsion marjalarning o'zgarishlari orqali modelning barqarorligini baholash imkonini beradi.

Asosiy raqobatchilar

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Sotuvning operatsion marjasi MNKD|AMPH: Operatsion foyda normasi|Operatsion rentabellik pacira.com (PCRX)|Operatsion marja ARS Pharma (SPRY)|Theravance Biopharma - Sotuvning operatsion marjasi|Operatsion foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Tectonic Therapeutic|TNXP: Operatsion marja|SXT China (SXTC) - Operatsion marja|Operatsion rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Invizyne (EXOZ)|ORMP - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.